June 2017 Issue of MMM

June 2017 Issue of MMM

Go Figure

Infographic: The battle for medication adherence

Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.

Pharma Report

Pricing pressure is the new new normal for drugmakers

Drug prices, as you may have heard, are kind of high. But price growth has slowed after sharp spikes in 2014 and 2015.

2017 Pharma Report: All the data in one place

Find data on patent expirations, new drug approvals, top therapeutic classes, and top-selling drugs.

MM&M Hall of Femme

Hall of Femme of 2017

For the second year, MM&M is honoring 16 of the most-senior women in the healthcare industry.

Leadership Exchange

Roundtable: Social centricity in oncology

Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family ...

Roundtable: When it comes to media, pharma compares the new with the old

In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.

Sponsored Content

Rebooting your approach to HUB services

A trio of industry leaders counsels on numerous HUB strategies that will help providers vastly improve the patient experience.

Using co-pay programs to acquire and engage patients

Along with lower costs, effective co-pay offset programs boost patient adherence and better connect with doctors and pharmacies.

Partner Content

Pharma must radically rethink its engagement with doctors

Amidst the massive technological and social changes upending the societal status quo, the culture of doctors around the globe is also in flux. Technology must ...

Editor's Desk

Keep Calm and Sell Drugs: Your New Daily Affirmation?

To be sure, anything borrowing from the well-known "Keep Calm" genre should not be construed as advice. The doctor is definitely not in.

Headliner

Back at Dendreon, Caggiano takes on Provenge's comeback

Jim Caggiano had witnessed Provenge's birth during an earlier turn at Dendreon and couldn't understand what went wrong.

Partner Forum

4 Ways to Communicate the Value of Specialty Drugs

Beset by high prices and scientific complexity, how can marketers best communicate the value of specialty drugs?

Private View

McCann Health's June Laffey on Why Change is Good in Health

The president of the 2017 Lions Health pharma jury shares campaigns that incorporate technology, innovation, and creative thinking to impact behaviors and change lives.

Back Talk

How to Shatter the Glass Ceiling

Healthcare marketing has a head start in grooming women leaders. But it's by no means a fait accompli.